GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Net Change in Cash

Nuformix (LSE:NFX) Net Change in Cash : £-0.09 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Nuformix's Net Change in Cash for the six months ended in Mar. 2025 was £0.08 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was £-0.09 Mil.


Nuformix Net Change in Cash Historical Data

The historical data trend for Nuformix's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Net Change in Cash Chart

Nuformix Annual Data
Trend Dec15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Sep24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only 0.54 1.13 -1.21 -0.21 -0.18

Nuformix Semi-Annual Data
Dec15 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24 Sep24 Mar25
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.13 -0.02 -0.16 0.08

Nuformix Net Change in Cash Calculation

Nuformix's Net Change in Cash for the fiscal year that ended in Sep. 2024 is calculated as

Nuformix's Net Change in Cash for the quarter that ended in Mar. 2025


Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Nuformix's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix Headlines

From GuruFocus

Newfield Exploration Company (NFX) EVP and CFO Terry W Rathert sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 09-17-2010

5 Oil & Gas Companies To Consider This Year

By InvestmentUnderground InvestmentUnderground 03-25-2012

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 23,000 Shares

By GuruFocus Research GuruFocus Editor 03-11-2010

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 10,000 Shares

By GuruFocus Research GuruFocus Editor 12-29-2009